The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology
Open accessAbstract
In addition to amyloid-β plaque and tau neurofibrillary tangle deposition, neuroinflammation is considered a key feature of Alzheimer’s disease pathology. Inflammation in Alzheimer's disease is characterized by the presence of reactive astrocytes and activated microglia surrounding amyloid plaques, implicating their role in disease pathogenesis. Microglia in the healthy adult mouse depend on colony-stimulating factor 1 receptor (CSF1R) signalling for survival, and pharmacological inhibition of this receptor results in rapid elimination of nearly all of the microglia in the central nervous system. In this study, we set out to determine if chronically activated microglia in the Alzheimer's disease brain are also dependent on CSF1R signalling, and if so, how these cells contribute to disease pathogenesis. Ten-month-old 5xfAD mice were treated with a selective CSF1R inhibitor for 1 month, resulting in the elimination of ∼80% of microglia. Chronic microglial elimination does not alter amyloid-β levels or plaque load; however, it does rescue dendritic spine loss and prevent neuronal loss in 5xfAD mice, as well as reduce overall neuroinflammation. Importantly, behavioural testing revealed improvements in contextual memory. Collectively, these results demonstrate that microglia contribute to neuronal loss, as well as memory impairments in 5xfAD mice, but do not mediate or protect from amyloid pathology. Microglia-mediated inflammation is a driving force in Alzheimer’s disease pathogenesis. Spangenberg et al . show that elimination of microglia in 5xfAD mice improves cognitive function and ameliorates synaptic/neuronal loss without altering amyloid-β levels or plaque load. Thus, microglia act downstream of plaques to mediate damage to the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In mice that serve as a model for Alzheimer’s disease, microglia depletion was generally beneficial by decreasing plaque formation (26).”
From Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection (2020) · cites this paper as [26]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In mouse models of AD genetic or pharmacological depletion of microglia prevented microglia association with amyloid plaques and neuronal loss, which led to improved learning and memory without affecting amyloid plaque load in mouse brain (Dagher et al., 2015; Rice et al., 2015; Spangenberg et al., 2016).”
From Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response (2021) · cites this paper as Spangenberg et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“microglia depletion before or after the formation of Aβ pathology in mouse models of AD resulted in improved contextual memory”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the use of these agents is limited in experimental TBI studies, several groups have reported that microglial elimination [via colony-stimulating factor 1 receptor (CSF1R) inhibition] improves behavioral performance and synaptic functioning independent of Aβ accumulation in multiple transgenic mouse models of AD (3xTg, 5xFAD, APP/PS1) (236–238).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [236]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Ablation of microglia in younger mice before development of cerebral amyloidosis thus reduces Aβ deposition [294], while ablation of microglia later in disease (i.e., in 10-month-old 5xFAD mice) [296], does not alter Aβ load.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that these cells are dispensable for Aβ clearance and plaque formation in the late stage of disease [296]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“microglia ablation in AD mouse models at 10 months of age had no impact on plaque burden”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
The cited source says what the claim attributes to it.
In the citing paper
“further implicating microglia in neuronal and/or synaptic loss [294–296]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [296]
In the citing paper
“Unlike with synapse loss, the formation and maintenance of β-amyloid plaques in amyloidosis models does not seem to be affected by CSF1R inhibition or other methods of microglia depletion (Grathwohl et al., 2009; Olmos-Alonso et al., 2016; Spangenberg et al., 2016).”
From Microglia in Alzheimer’s disease (2018) · cites this paper as Spangenberg et al., 2016
In the citing paper
“For instance, synaptic loss is a key feature of AD pathogenesis mediated, at least in part, by microglia [13, 79].”
From Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain (2020) · cites this paper as [13]
In the citing paper
“We previously reported that neuronal and synaptic genes (e.g. Dlk2, Kcnq3, Nrg3, Scn1b) and related functional pathways (e.g. synaptic vesicles, glutamate receptors, neuronal membranes) were extensively and uniquely downregulated in the 7mo 5xFAD hippocampus compared to WT hippocampus and other 5xFAD brain regions [12], respectively, in addition to a loss of subiculum neurons and dendritic spines”
From Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain (2020) · cites this paper as [13]
In the citing paper
“yet the removal of the microglia at advanced stages of pathology protects against synaptic and neuronal loss10.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“The absence of microglia did not significantly alter the levels of Aβ38, Aβ40, or Aβ42, in detergent-soluble or -insoluble cortical and thalamic homogenates in either the 4- or 7- month cohorts (Fig. 5a–h), in line with multiple studies showing that CSF1R inhibition does not affect Aβ production/clearance10,27,28.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“Despite this response, however, Aβ clearance and plaque modulation/dynamics is unaffected10–12”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“No statistical methods were used to predetermine sample sizes; however, our sample sizes are similar to those reported in recently published similar studies10,28.”
From Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model (2019) · cites this paper as [10]
In the citing paper
“Consistent with a potential detrimental role of microglia, it was shown that ablation of microglia by a compound (PLX3397) that inhibits CSF1R did not reduce plaque burden, although it did protect synapses185.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [185]
In the citing paper
“However, global microglial depletion in AD mouse models resulted in a protective effect on synaptic health, independent of amyloid β [18, 19].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [18]
In the citing paper
“depleting microglia after amyloid-β pathology onset via pharmacological inhibition of colony-stimulating factor 1 receptor (CSF1R) signalling38 or by using the CD11b-HSVTK (TK) system39 for 4 weeks, does not affect total plaque burden.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 4×
“The 5xfAD mice represent an aggressive model of amyloid pathologies, with amyloid-b plaques first depositing from 2 months of age (Oakley et al., 2006).”
BackgroundMethodInfluentialHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
Self-citationNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 695
Transcorneal electrical stimulation enhances cognitive functions in aged and 5XFAD mouse models
Yu, W. S., Aquili, L., Wong, K. H., Lo, A., Chan, L. L. H., Chan, Y., & Lim, L. W. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14850 · Cited by 17
Deciphering microglial diversity in Alzheimer's disease
Brown, G. C., & George‐Hyslop, P. S. (2017) · Science · doi:10.1126/science.aan7893 · Cited by 18
Lei, F., Cui, N., Zhou, C., Chodosh, J., Vavvas, D. G., & Paschalis, E. I. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020660118 · Cited by 17
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 17
Lin, Y.-S., Liu, C., Lee, H., Chou, M., Ke, L., Chen, C., & Chen, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-85502-0 · Cited by 16
Wendt, S., Johnson, S., Weilinger, N. L., Groten, C., Sorrentino, S., Frew, J., Yang, L., Choi, H. B., Nygaard, H. B., & MacVicar, B. A. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102448 · Cited by 20
Ennerfelt, H. E., Holliday, C., Shapiro, D. A., Zengeler, K. E., Bolte, A. C., Ulland, T. K., & Lukens, J. R. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2303760120 · Cited by 16
Rethinking the network determinants of motor disability in Parkinson’s disease
Surmeier, D. J., Zhai, S., Cui, Q., & Simmons, D. V. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1186484 · Cited by 17
VEGF controls microglial phagocytic response to amyloid-β
Gea, P. D., Benkeder, S., Bouvet, P., Aimard, M., Chounlamountri, N., Honnorat, J., Do, L.-D., & Meissirel, C. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1264402 · Cited by 19
Abd‐Elrahman, K. S., Colson, T. L., Sarasija, S., & Ferguson, S. S. G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116388 · Cited by 18
Li, X., Shan, J., Liu, X., Huang, Z., Xu, G., & Ren, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112473 · Cited by 16
Updating Neuroimmune Targets in Central Nervous System Dysfunction
Valente, L. A., Begg, L. R., & Filiano, A. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.013 · Cited by 16
The 5×FAD mouse model of Alzheimer's disease
Ismeurt, C., Giannoni, P., & Claeysen, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815854-8.00013-6 · Cited by 18
Mancini, V. S. B. W., Pietro, A. A. D., de Olmos, S., Pinto, P. S., Vence, M., Marder, M., Igaz, L. M., Marcora, M. S., Pasquini, J. M., Correale, J. D., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15566 · Cited by 16
Ji, Z., Zhang, X., Ji, L., & Jiang, G. (2022) · BioMed Research International · doi:10.1155/2022/9920744 · Cited by 16
Three-way interaction model to trace the mechanisms involved in Alzheimer’s disease transgenic mice
Khayer, N., Marashi, S., Mirzaie, M., & Goshadrou, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184697 · Cited by 16
Neuregulin-1 Fosters Supportive Interactions between Microglia and Neural Stem/Progenitor Cells
Shahriary, G. M., Kataria, H., & Karimi‐Abdolrezaee, S. (2019) · Stem Cells International · doi:10.1155/2019/8397158 · Cited by 16
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249441 · Cited by 17
Ding, L., Meng, Y., Zhang, H., Yin, W., Yan, Y., & Cao, Y. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.01.003 · Cited by 15
Gervais, É., Iloun, P., Martianova, E., Bessa, A. C. G., Rivest, S., & Topolnik, L. (2021) · The Journal of Comparative Neurology · doi:10.1002/cne.25289 · Cited by 15
Wang, Y., Du, Y., Huang, H., Cao, Y., Pan, K., Zhou, Y., He, J., Yao, W., Chen, S., & Gao, X. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107133 · Cited by 15
Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
Heuer, S. E., Bloss, E. B., & Howell, G. R. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109987 · Cited by 16
The intricate interplay between microglia and adult neurogenesis in Alzheimer’s disease
Früholz, I., & Meyer‐Luehmann, M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1456253 · Cited by 16
CCR2 downregulation attenuates spinal cord injury by suppressing inflammatory monocytes
Zhang, Q., Zhu, C., Li, X., Shi, Y., & Zhang, Z. (2020) · Synapse · doi:10.1002/syn.22191 · Cited by 15
Gaigé, S., Barbouche, R., Barbot, M., Boularand, S., Dallaporta, M., Abysique, A., & Troadec, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02631-7 · Cited by 15
Walker, D. J., Zimmer, C., Larriva, M., Healy, S. D., & Spencer, K. A. (2019) · Journal of Experimental Biology · doi:10.1242/jeb.187039 · Cited by 15
Ghosh, A., Chen, F., Wu, F., Tang, S., Hu, M. Y., Long, Y., Sun, H., Kong, L., & Hong, H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.10.001 · Cited by 15
Altered circadian behavior and light sensing in mouse models of Alzheimer’s disease
Weigel, T. K., Guo, C. L., Güler, A. D., & Ferris, H. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1218193 · Cited by 15
Henningfield, C. M., Soni, N., Lee, R. W., Sharma, R. B., Cleland, J. L., & Green, K. N. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01470-3 · Cited by 14
Self-citationIs Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
Katsel, P., & Haroutunian, V. H. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/vharoutunian · Cited by 14
Romero‐Molina, C., Navarro, V., Jiménez, S., Muñoz‐Castro, C., Sanchez-Mico, M. V., Gutiérrez, A., Vitórica, J., & Vizuete, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189734 · Cited by 14
Torii, K., Takagi, S., YOSHIMURA, R., & Miyata, S. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577832 · Cited by 14
Zeller, M. V., Sebastião, A. M., & Valente, C. A. (2022) · Biomolecules · doi:10.3390/biom12050666 · Cited by 14
Multitasking Microglia and Alzheimer’s Disease: Diversity, Tools and Therapeutic Targets
Grubman, A., Kanninen, K. M., & Malm, T. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0825-5 · Cited by 14
Microglia depletion and cognitive functions after brain injury: From trauma to galactic cosmic ray
Paladini, M. S., Feng, X., Krukowski, K., & Rosi, S. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135462 · Cited by 16
Wendt, S., Lin, A. J., Ebert, S. N., Brennan, D. J., Cai, W., Bai, Y., Kong, D. Y., Sorrentino, S., Groten, C. J., Lee, C., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03433-3 · Cited by 13
Zhang, F., Yang, W., Sun, R., Duan, X., 杨云华, Wang, A., & Tian, Y. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251401591 · Cited by 13
Microglial CD2AP deficiency exerts protection in an Alzheimer’s disease model of amyloidosis
Zhang, L., Huang, L., Zhou, Y., Meng, J., Zhang, L., Zhou, Y., Zheng, N., Guo, T., Zhao, S., Wang, Z., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00789-7 · Cited by 13
Exploring microglial replacement: From disease models to clinical translation
Zhou, K., Wang, Y., Xu, Y., Zhang, Y., & Zhu, C. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.06.011 · Cited by 13
Gaunt, J. R., Zainolabidin, N., Yip, A. K. K., Tan, J. M., Low, A. Y. T., Chen, A. I., & Ch’ng, T. H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02913-8 · Cited by 12
Microglia–Neuron Crosstalk: An Intimate Molecular Conversation in Neurodegeneration
Wang, S., Wang, S., Hongzhuan, C. H. E. N., & Xu, J. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27042011 · Cited by 13
Resolving heterogeneity in Alzheimer's disease based on individualized structural covariance network
Zheng, C., Zhao, W. D., Yang, Z., Tang, D., Feng, M., & Guo, S. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110873 · Cited by 13
Characterizing Microglial Signaling Dynamics During Inflammation Using Single‐Cell Mass Cytometry
Kumar, S., Kahle, A. D., Keeler, A. B., Zunder, E. R., & Deppmann, C. D. (2025) · Glia · doi:10.1002/glia.24670 · Cited by 8
Le, L., Eliseeva, S. I., Plunk, E. C., Kara-Pabani, K., Li, H., Yarovinsky, F., & Majewska, A. K. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115176 · Cited by 13
The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration
Öztürk, M. M., Emgård, J., García‐Revilla, J., Fernández‐Calle, R., Yang, Y., Deierborg, T., & Roos, T. T. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf087 · Cited by 14
Clec7a Signaling in Microglia Promotes Synapse Loss Associated with Tauopathy
Yang, S., Wang, J., Cao, Y., Zhang, Y., Sun, Z., Wan, P., Pi, M., Xiong, Q., Shu, X., Wang, X., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072888 · Cited by 12
Onaolapo, O. J., Olofinnade, A. T., Ojo, F. O., & Onaolapo, A. Y. (2021) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523021666220815151559 · Cited by 12
The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
You, G., Yao, J., Liu, Q., & Li, N. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120421 · Cited by 12
Shi, G., Zhang, C., Li, G., Wang, K., Cai, Q., & Huang, M. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114583 · Cited by 12
Microglia activation mediates circadian rhythm disruption-induced cognitive impairment in mice
Meng, D., Yang, M., Zhang, H., Zhang, L., Song, H., Liu, Y., Zeng, Y., Yang, B. K., Wang, X., Chen, Y., et al. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578102 · Cited by 12
vonderEmbse, A., Hu, Q., & DeWitt, J. (2017) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417000277 · Cited by 11
TREM2: Keeping Microglia Fit during Good Times and Bad
Hong, S. Y., & Stevens, B. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.010 · Cited by 13
Amyloid-β-activated microglia can induce compound proteinopathies
Lee, S. H., Bae, E.-J., Pérez-Acuña, D., Jung, M. K., Han, J. W., Mook‐Jung, I., & Lee, S. (2024) · Brain · doi:10.1093/brain/awae221 · Cited by 11
Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers
Zou, J., McNair, E. M., DeCastro, S., Lyons, S. P., Mordant, A. L., Herring, L. E., Vetreno, R. P., & Coleman, L. G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03208-2 · Cited by 13
Satellite microglia: marker of traumatic brain injury and regulator of neuronal excitability
Feichtenbiner, A., Sytsma, K., O’Boyle, R. P., Mittenzwei, R., Maioli, H., Scherpelz, K. P., Child, D. D., Li, N., Ariza, J., Keene, L. M., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03328-9 · Cited by 11
Wang, M., Chen, D., Pan, R., Sun, Y., He, X., Qiu, Y.-Y., Hu, Y., Wu, X., Xi, X., Hu, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1548206 · Cited by 11
Jiao, H., Ge, Y., Huang, L.-Y., Liu, Y., Wu, B., Lian, P., Hao, Y., Han, S., Li, Y., Wu, K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00887-0 · Cited by 11
Milinkeviciute, G., Chokr, S. M., & Cramer, K. S. (2021) · eNeuro · doi:10.1523/eneuro.0318-20.2021 · Cited by 12
Battis, K., Florio, J. B., Mante, M., Lana, A. J., Naumann, I., Gauer, C., Lambrecht, V., Müller, S. J., Cobo, I., Fixsen, B. R., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.0417-22.2022 · Cited by 13
Heuer, S. E., Keezer, K. J., Hewes, A. A., Onos, K. D., Graham, K., Howell, G. R., & Bloss, E. B. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13440 · Cited by 11
Microglia depletion/repopulation does not affect light-induced retinal degeneration in mice
Laudenberg, N., Kinuthia, U. M., & Langmann, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1345382 · Cited by 12
Steffen, J., Stenzel, J., Ibrahim, S. M., & Pahnke, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180395 · Cited by 11
Clayton, E. L., Mancuso, R., Nielsen, T. T., Mizielinska, S., Holmes, H., Powell, N., Norona, F., Overgaard Larsen, J., Milioto, C., Wilson, K. M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx003 · Cited by 32
Ma, X., Prokopenko, D., Wang, N., Aikawa, T., Choi, Y., Zhang, C. M., Lei, D., Ren, Y., Kawatani, K., Starling, S. C., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106813 · Cited by 10
Microglia replacement by peripheral delivery of CSF1R inhibitor-resistant hematopoietic cells
Lombroso, S. I., Church, E. I., Anderson, R. N., O’Brien, C. A., Zhu, Y., Dar, A. A., Purnell, F. S., Levitt, E. M., Temsamrit, B., Yaqoob, F., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.10.050 · Cited by 10
Self-citationConnectome-based biophysics models of Alzheimer’s disease diagnosis and prognosis
Torok, J., Anand, C., Verma, P., & Raj, A. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.008 · Cited by 11
Liu, J., Zhang, X., Xu, Y., & Zhang, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03557-8 · Cited by 11
Headmasters: Microglial regulation of learning and memory in health and disease
Weinhard, L., d’Errico, P., & Tay, T. L. (2018) · AIMS molecular science · doi:10.3934/molsci.2018.1.63 · Cited by 11
Wu, C. M., & Lai, T. W. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147391 · Cited by 10
Wickstead, E. S., Irving, M. A., Getting, S. J., & McArthur, S. (2021) · FEBS Journal · doi:10.1111/febs.15861 · Cited by 10
Ogaki, A., Ikegaya, Y., & Koyama, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.918442 · Cited by 10
Repositioning of receptor tyrosine kinase inhibitors
Mansour, H. M., & El-Khatib, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00010-5 · Cited by 9
Glial cells as a promising therapeutic target of glaucoma: beyond the IOP
Shinozaki, Y., Namekata, K., Guo, X., & Harada, T. (2024) · Frontiers in Ophthalmology · doi:10.3389/fopht.2023.1310226 · Cited by 9
Mu, R.-H., Hou, X., Liu, Q., Wang, W., Qin, C., & Li, H. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111786 · Cited by 9
Potential Alzheimer’s disease drug targets identified through microglial biology research
Lepiarz‐Raba, I., Hidayat, T., Hannan, A. J., & Jawaid, A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2335210 · Cited by 9
Association between CSF1 and CSF1R Polymorphisms and Parkinson’s Disease in Taiwan
Chang, K., Wu, Y., Chen, Y., Wu, H.-C., & Chen, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101529 · Cited by 9
Ni, J., & Wu, Z. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.638686 · Cited by 9
Lin, G.-Q., He, X., Liu, B., Wei, C., Tao, R., Yang, P., Pei, Z., & Mo, Y. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.09.046 · Cited by 8
Le, L., O’Banion, M. K., & Majewska, A. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-81910-0 · Cited by 8
Repopulation of microglia and its implications for CNS disorders: Insights from the single-cell era
Chen, C., Qiao, G., Tang, D., Xu, F., Dong, J., Zhang, J., & Jin, B. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107066 · Cited by 8
Gallo, C., Verrillo, L., Manzo, E., Cauzzi, E., Barbera, L. L., Sabatino, G., Paolis, M. L. D., Sciacca, M. F. M., Barra, G., Peroni, E., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03634-w · Cited by 8
Border-associated macrophages: From physiology to therapeutic targets in Alzheimer's disease
Zheng, F., Dong, T., Chen, Y., Wang, L., & Peng, G. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115021 · Cited by 8
Development of cerebral microhemorrhages in a mouse model of hypertension
Xie, D. F., Fang, C., Crouzet, C., Hung, Y.-H., Vallejo, A., Lee, D., Liu, J., Liu, H., Muvvala, S., Paganini‐Hill, A., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03378-7 · Cited by 8
Lim, S., Tran, D. N., Kieu, Z., Chen, C., Villanueva, E., Ghiaar, S., Gallup, V., Zumkehr, J., Cribbs, D. H., Rodríguez‐Ortiz, C. J., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01894-6 · Cited by 8
Functional border-associated macrophages limit Alzheimer’s Disease progressionPreprint
Adler, D. I., Pinheiro-Rosa, N., Millet, A., Gajic, Z. Z., Cheng, E., Gamallo‐Lana, B., Morizawa, Y. M., Klann, E., Gan, W., Mar, A. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.31.703045 · Cited by 8
Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer’s disease
Zhang, L., Chen, K., Zeng, R., Bu, G., & Chen, X.-F. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03558-5 · Cited by 7
Evolutionary sex bias in cognitive response to new environmental risk factor - PM2.5
Chen, H., Verkhratsky, A., Yi, C., & Oliver, B. G. G. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00774-9 · Cited by 7
Evolving insights into the identity and function of dark microglia
Flury, A. G., St‐Pierre, M., Ayata, P., & Tremblay, M. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.11.002 · Cited by 7
Hayden, E. Y., Huang, J., Charreton, M., Nuñez, S., Putman, J. N., Teter, B., Lee, J. T., Welch, A. E., Frautschy, S. A., Cole, G. M., et al. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00786-0 · Cited by 7
Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer 's disease
Horibe, S., Emoto, T., Mizoguchi, T., Tanaka, T., Kawauchi, S., Sasaki, N., Yamashita, T., Ikeda, K., Emoto, N., Hirata, K., et al. (2023) · Glia · doi:10.1002/glia.24461 · Cited by 7
Cancer drugs with high repositioning potential for Alzheimer’s disease
Majeed, J., Sabbagh, M. N., Kang, M. H., Lawrence, J. J., Pruitt, K., Bacus, S. S., Reyna, E., Brown, M., & Decourt, B. (2023) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2023.2296079 · Cited by 9
Adhikari, A., Chauhan, K., Adhikari, M., & Tiwari, A. K. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117628 · Cited by 7
Yang, L., Gomm, A., Bai, P., Ding, W., Tanzi, R. E., Wang, C., Shen, S., & Zhang, C. M. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007239 · Cited by 8
Salvianolate reduces neuronal apoptosis by suppressing OGD-induced microglial activation
Luan, P., Ding, X., Xu, J., Jiang, L., Xu, Y., Zhu, Y., Li, R., & Zhang, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118393 · Cited by 7
Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis
Padovani, A., Canale, A., Schiavon, L., Masciocchi, S., Imarisio, A., Risi, B., Bonzi, G., Giuli, V. D., Luca, M. D., Ashton, N. J., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12554 · Cited by 7
Sharon, A., Jankowski, M. M., Shmoel, N., Erez, H., & Spira, M. E. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.01.002 · Cited by 7
Microglia have limited influence on early prion pathogenesis, clearance, or replication
Race, B., Williams, K., Baune, C., Striebel, J. F., Long, D., Thomas, T., Lubke, L. L., Chesebro, B. W., & Carroll, J. A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276850 · Cited by 8
Zhu, Q., Song, Y., Qian, Y., Zhang, R., Xue, J., & Hou, Y. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.25 · Cited by 6
Zong, L., Chen, P., Shi, J., Chen, H., Lin, W., Ou, G., & Chen, X. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1695058 · Cited by 6
Palumbo, G., Kunze, L. H., Oos, R., Wind-Mark, K., Lindner, S., von Ungern‐Sternberg, B., Bartenstein, P., Ziegler, S. I., & Brendel, M. (2023) · Animals · doi:10.3390/ani13111812 · Cited by 7
Metadata
- Authors
- Spangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N.
- Affiliations
- University of California, Irvine (US)
- Plexxikon (United States) (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-02-26
- Volume
- 139
- Issue
- 4
- Pages
- 1265-1281
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5006229
- OpenAlex
- W2281702574
- Semantic Scholar
- 82920544f365b661b1f2e68abe91acd0c7d6f7f8
- Cited by
- 695
- References
- 88
- Citations by year
- 2026: 44 · 2025: 63 · 2024: 66 · 2023: 79 · 2022: 80 · 2021: 90 · 2020: 80 · 2019: 62 · 2018: 66 · 2017: 48 · 2016: 16
- FWCI
- 31.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Brain (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Alzheimer's Association
- Glenn Foundation for Medical Research
- Plexxikon
- National Institutes of Health (UL1TR001414, AG00096, AG00538)
- National Institute on Aging (AG00096, AG 00538, P50AG016573, T32AG000096)
- National Institute of Neurological Disorders and Stroke (F31NS086409, R01NS083801)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- microglia, Alzheimer's disease, CSF1R inhibition, neuroinflammation, amyloid plaques, neuronal loss, dendritic spine loss, 5xFAD mice, contextual memory, synaptic loss
- MeSH terms
- Alzheimer Disease, Animals, Brain, Female, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Amyloid beta-Peptides, Microglia, Mice, Mice, 129 Strain, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
